This is to inform you that the Earnings Conference Call for Investors and Analysts has been scheduled on Tuesday, May 26, 2026 at 4:00 P.M. (IST) to discuss the Company''s Q4 FY26 Financial Results.

Board & Shareholder Meetings View source PDF

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.3%1-day move

₹707.10

prior close

₹704.35

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2-0.1+0.0-0.0-0.3+0.6+3.5-1.8-7.4-9.3-12.3-4.1-1.0—

Up moveDown movePending

AI summary

Aarti Pharmalabs has scheduled an earnings conference call for Tuesday, May 26, 2026 at 4:00 PM IST to discuss Q4 FY26 financial results. The call is hosted by YES Securities (India) Ltd and will feature key management including Chairman Rashesh Gogri, Vice Chairperson Hetal Gogri Gala, and CFO Piyush Lakhani. The company is listed on both BSE (scrip code 543748) and NSE (symbol AARTIPHARM). This filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015, which mandates timely disclosure of material events to stock exchanges.

Likely market impact

This is a routine regulatory filing informing investors and analysts about an upcoming earnings call. No material new information is disclosed. Shareholders and analysts should note the date to participate in the call where Q4 FY26 results will be discussed.